Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up - Time to Buy?

Key Points

• Hypermarcas shares gapped up from a previous close of $4.04 to open at $4.23, with a trading volume of 361 shares.
• Scotiabank upgraded Hypermarcas to a "strong-buy" rating, suggesting positive market sentiment regarding the company's growth potential.
• The company announced a dividend payout of $0.0345, which reflects an impressive yield of 281.0% for investors of record.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $4.04, but opened at $4.23. Hypermarcas shares last traded at $4.23, with a volume of 361 shares traded.

Wall Street Analyst Weigh In

Separately, Scotiabank upgraded shares of Hypermarcas to a "strong-buy" rating in a report on Thursday, July 17th.

Hypermarcas Stock Performance

The company has a market capitalization of $2.60 billion, a price-to-earnings ratio of 19.52 and a beta of 0.77. The company has a 50 day moving average price of $4.71 and a 200 day moving average price of $4.03. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Dividend Announcement

The business also recently announced a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be given a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a dividend yield of 281.0%. Hypermarcas's payout ratio is presently 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.